Taysha Gene Therapies, Inc. (TSHA)

5.77 -3.19% (-0.19)

Over 3Y: +146.6%

2026-08-28
Style
Area Line Line with markersneeds a shorter window Steps Candlesneeds a shorter window Hollow candlesneeds a shorter window Barsneeds a shorter window

Candles need the day’s open, high and low. Those are being collected now — a company shows them once its history has been refreshed.

2 4 6
2023 2024 2025 2026

Financials Quarterly

Figures
Revenue Gross Profit Operating Income Cost of Revenue Operating Cash Flow Free Cash Flow Net Income

A share count and earnings a share are not here: neither is money, so neither can share this axis. Both have their own panel on All charts.

All charts ›
Q3 '21 — Operating Cash Flow: -31.9M Q3 '21 — Free Cash Flow: -35.4M Q4 '21 — Operating Cash Flow: -40.3M Q4 '21 — Free Cash Flow: -48.5M Q1 '22 — Operating Cash Flow: -40.9M Q1 '22 — Free Cash Flow: -49.4M Q2 '22 — Operating Cash Flow: -33.4M Q2 '22 — Free Cash Flow: -41.2M Q3 '22 — Operating Cash Flow: -28.8M Q3 '22 — Free Cash Flow: -30.8M Q4 '22 — Operating Cash Flow: 14.7M Q4 '22 — Free Cash Flow: 12.4M Q1 '23 — Revenue: 4.7M Q1 '23 — Operating Cash Flow: -20.2M Q1 '23 — Free Cash Flow: -24.1M Q2 '23 — Revenue: 2.4M Q2 '23 — Operating Cash Flow: -18.8M Q2 '23 — Free Cash Flow: -18.8M Q3 '23 — Revenue: 4.7M Q3 '23 — Operating Cash Flow: -17.9M Q3 '23 — Free Cash Flow: -17.9M Q4 '23 — Revenue: 3.6M Q4 '23 — Operating Cash Flow: -16.1M Q4 '23 — Free Cash Flow: -16.1M Q1 '24 — Revenue: 3.4M Q1 '24 — Operating Cash Flow: -19.8M Q1 '24 — Free Cash Flow: -19.9M Q2 '24 — Revenue: 1.1M Q2 '24 — Operating Cash Flow: -21.5M Q2 '24 — Free Cash Flow: -21.7M Q3 '24 — Revenue: 1.8M Q3 '24 — Operating Cash Flow: -21.6M Q3 '24 — Free Cash Flow: -21.6M Q4 '24 — Revenue: 2M Q4 '24 — Operating Cash Flow: -18.3M Q4 '24 — Free Cash Flow: -18.3M Q1 '25 — Revenue: 2.3M Q1 '25 — Operating Cash Flow: -22M Q1 '25 — Free Cash Flow: -22.4M Q2 '25 — Revenue: 2M Q2 '25 — Operating Cash Flow: -20.2M Q2 '25 — Free Cash Flow: -20.2M Q3 '25 — Revenue: 0 Q3 '25 — Operating Cash Flow: -24.2M Q3 '25 — Free Cash Flow: -24.3M Q4 '25 — Revenue: 5.5M Q4 '25 — Operating Cash Flow: -26.7M Q4 '25 — Free Cash Flow: -27M Q1 '26 — Revenue: 0 Q1 '26 — Operating Cash Flow: -40.9M Q1 '26 — Free Cash Flow: -40.9M Q2 '26 — Revenue: 0 Q2 '26 — Operating Cash Flow: -40.4M Q2 '26 — Free Cash Flow: -40.4M -45M -30M -15M 0 15M
Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26
Revenue Operating Cash Flow Free Cash Flow

Figures as at 2026-06-30, reported in USD. The newest fact in the filings is dated 2026-06-30, 61 days ago. Nothing on this page is advice.

How it scores

Five questions, each answered by the measures under it. Every figure is the company's own; the bar beside it is where that figure sits among the companies read here — the top fifth, the bottom fifth, or somewhere between. Not among all listed companies, and for a valuation multiple the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

0.8
SBC / sales 331.3%
Accruals -3.7%
Asset turnover 0.012×
FCF margin -2417.0%
ROA -31.8%
ROCE -34.5%
ROE -38.6%
EBITDA margin —
Gross margin —
OCF / EBIT —
OCF margin —
OE margin —
Oper. margin —
Profit margin —
ROIC —

2 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

0.5
Div. yield —
EV/EBIT —
EV/GP —
EV/OE —
EV/Sales —
FCF yield —
Fwd P/E —
P/B —
P/C —
P/E —
PEG —

0 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

4.5
RPO / sales 1.0×
RPO growth —
Segment HHI —

3 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

6.5
Current ratio 22.5×
ND/EBITDA —
Interest cover -3646.6×
Cash / Debt 9.2×
Debt / Eq 0.13×
Debt payback 0.0 yr
Quick ratio 17.8×
Cash runway 3.1 yr
F-score 4.5 pts
Payout —

3 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

4.0
Sales/sh Y/Y -47.0%
Sales Q/Q -100.0%
Shares change +27.8%
Div. growth —
EBIT CAGR —
EBIT Y/Y —
EPS CAGR 4Y —
EPS Y/Y —
EPS next Y —
Sales CAGR 4Y —

3 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.